This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Schilling MB, Parks C, Deeter RG.Costs and outcomes associated with febrile neutropenia-related hospitalizations across patients with varying cancer types: a retrospective analysis. 45th Annual Meeting of the American Society of Clinical Oncology: abstr. e20560, 29 May 2009. Available from: URL: http://www.abstract.asco.org
Duh M, Toy EL, Porter CL, Books PL, Vekeman F, Barghout V, Skarin AT.Budget impact analysis of sargramostim use in patients with chemotherapy-induced neutropenia. 45th Annual Meeting of the American Society of Clinical Oncology: abstr. e20596, 29 May 2009. Available from: URL: http://www.abstract.asco.org
Rights and permissions
About this article
Cite this article
Chemo-induced neutropenia: impact under-appreciated. Pharmacoecon. Outcomes News 581, 7 (2009). https://doi.org/10.2165/00151234-200905810-00017
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905810-00017